glp-1 in type 2 diabetes RA education GLP1 Receptor Agonists vs SGLT2-I
Description
Available from: 26.Naver SV, Jimenez-Solem E, Christensen M, Andersen JT, Knop FK
doi: 10.1039/C9BM01426H
doi: 10.1186/s40035-017-0099-z 90 KaliaLVLangAE
Can You Stop Taking a GLP-1
Safety Issues With Glucagon-Like Peptide-1 Receptor Agonists (Pancreatitis, Pancreatic Cancer and Cholelithiasis): Data From Randomized Controlled Trials
B.BenassiJ
